Details for New Drug Application (NDA): 021454
✉ Email this page to a colleague
The generic ingredient in TESTIM is testosterone. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 021454
| Tradename: | TESTIM |
| Applicant: | Endo Operations |
| Ingredient: | testosterone |
| Patents: | 0 |
Pharmacology for NDA: 021454
| Mechanism of Action | Androgen Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 021454
Suppliers and Packaging for NDA: 021454
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TESTIM | testosterone | GEL;TRANSDERMAL | 021454 | NDA | Endo USA, Inc. | 66887-001 | 66887-001-05 | 30 TUBE in 1 CARTON (66887-001-05) / 5 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TRANSDERMAL | Strength | 50MG/5GM PACKET | ||||
| Approval Date: | Oct 31, 2002 | TE: | AB2 | RLD: | Yes | ||||
Expired US Patents for NDA 021454
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Endo Operations | TESTIM | testosterone | GEL;TRANSDERMAL | 021454-001 | Oct 31, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| Endo Operations | TESTIM | testosterone | GEL;TRANSDERMAL | 021454-001 | Oct 31, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| Endo Operations | TESTIM | testosterone | GEL;TRANSDERMAL | 021454-001 | Oct 31, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| Endo Operations | TESTIM | testosterone | GEL;TRANSDERMAL | 021454-001 | Oct 31, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| Endo Operations | TESTIM | testosterone | GEL;TRANSDERMAL | 021454-001 | Oct 31, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
